Advancing the Frontier of Metabolic Research
Streamline your laboratory protocols with ready-to-deploy peptide solutions. Each pen is pre-calibrated for exact micro-dosing, synthesised to >99% analytical purity, and packaged to preserve compound integrity from bench to analysis.
99% HPLC Verified
Pre-Calibrated Precision Dosing
Cold chain dispatched
18+ only – Research use only not for human consumption – Not for medical use – >99% purity
SECURE PAYMENT & VERIFICATION NOTICE
When paying by card, you are purchasing crypto through an independent, regulated payment provider to complete your order.
•Your Privacy is Protected: We do not see, store, or have access to any card details, personal data, or verification (KYC) documents you enter. This is a standard regulatory check handled strictly by the payment gateway.
.Prefer Not to Verify Here? You can buy crypto on any external platform of your choice (such as Kraken, Coinbase, or Revolut) and select Direct Crypto Transfer at checkout to pay our wallet directly.
100+
Products
99%
Purity
101k+
Verifications
2019
Founded
Our products
Research-Grade Retatrutide,
Batch-Tested
THE RETANOVA STANDARD
Uncompromising Purity
& Logistics
Just-in-Time Reconstitution
Glucagon-like peptide-1 receptor activation suppresses appetite and slows gastric emptying, reducing caloric intake in testing models.
Bacteriostatic Water (0.9% BnOH)
Glucagon-like peptide-1 receptor activation suppresses appetite and slows gastric emptying, reducing caloric intake in testing models.
Temperature- Controlled Transport
Glucagon-like peptide-1 receptor activation suppresses appetite and slows gastric emptying, reducing caloric intake in testing models.
Third-Party BatchTesting
Glucagon-like peptide-1 receptor activation suppresses appetite and slows gastric emptying, reducing caloric intake in testing models.
Verified COAs Provided
Glucagon-like peptide-1 receptor activation suppresses appetite and slows gastric emptying, reducing caloric intake in testing models.
UV-Resistant Packaging
Glucagon-like peptide-1 receptor activation suppresses appetite and slows gastric emptying, reducing caloric intake in testing models.
